A new but a fast growing medical technologies company by the name, Everist Genomics has been able to successfully combine Smartphone and the tablets with useful medical diagnostics in areas such as heart diseases, cancer as well as others. The device that can do all of this, is Everist Genomics “CardioDefender”. This device is the world’s first ever FDA-approved Smartphone ECG system, which is capable of providing patients as well as physicians with accurate heart monitoring outside the hospital.
This brand-new device is capable of using unique features to allow doctors to know of and treat conditions, which can be life threatening. The CardioDefender is the first system in this world, which is capable of delivering mobile, real-time, beat-by-beat as well as quantitative heart monitoring and automated reporting. The device can do so by combining patented analytical Smartphone software with its unique Wi-Fi and electrodes.
The CardioDefender can do all of this by using a bracelet sensor. This sensor collects the required data and sends it to your device, which analyzes the data and saves it. If something wrong is present in the body, the person gets an instant alert, and this alert is also sent to the doctor as well.
The CardioDefender has already been sent to more than 150 medical facilities in the United States of America. After a post-approval commercial evaluation, this device will be available to physicians all over the world, and it will definitely save a lot of lives!
If you’re looking for more devices that are to come out later this year then read my post about the top ten anticipated releases of 2012.
(VIA)
Follow us on Twitter and Facebook for all the news and latest updates!
Related posts:
